Personalized therapeutic stories for children after kidney transplant.
Generating Personalized Stories With Artificial Intelligence for Pediatric Kidney Recipients
We will test whether clinician-supervised AI can create age-appropriate, personalized therapeutic stories for children aged 5–12 who have received a kidney transplant and their families.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 5 Years to 12 Years |
| Sex | All |
| Sponsor | Paris Translational Research Center for Organ Transplantation Academic / other |
| Locations | 1 site (Paris, Île-de-France Region) |
| Trial ID | NCT07532382 on ClinicalTrials.gov |
What this trial studies
This observational project develops an AI-assisted workflow that uses large language models to generate age-adapted, personalized therapeutic stories for pediatric kidney transplant recipients and their families. Clinicians supervise story generation and tailor content via interviews and iterative feedback to ensure medical accuracy and emotional safety. Participants aged 5–12 who are clinically stable and fluent in French or English will receive AI-generated stories and be followed for acceptability, usability, and psychosocial outcomes. The study is conducted at Necker Hospital in Paris and focuses on feasibility and refinement rather than testing clinical efficacy.
Who should consider this trial
Good fit: Children aged 5–12 who have received a kidney transplant, are clinically stable, fluent in French or English, and whose parents/guardians can provide consent and commit to study visits are ideal candidates.
Not a fit: Children with severe cognitive impairment, an unstable clinical course (such as active rejection or hospitalization), families unable to participate in interviews, or non–French/English speakers are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the approach could provide a scalable, clinician-approved way to help children process transplant experiences, reduce anxiety, and support family communication.
How similar studies have performed: Narrative and therapeutic storytelling have shown benefit in pediatric psychosocial care, but the use of clinician-supervised large language models to generate personalized stories for transplant patients is novel and not yet proven.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 5-12 years inclusive at enrolment. * Recipient of a kidney transplant. * Clinically stable at enrolment (no active rejection, acute infection, or current hospitalization for a graft-related complication). * Fluency in French or English. * Written informed consent from parent(s)/legal guardian(s); child assent when age-appropriate. Exclusion Criteria: * Severe cognitive impairment precluding engagement with narrative content. * Mental state not allowing participation. * Family unwilling or unable to commit to the study timeline and interview requirements.
Where this trial is running
Paris, Île-de-France Region
- Necker hospital — Paris, Île-de-France Region, France (Recruiting)
Study contacts
- Principal investigator: Marc Raynaud, PhD — Paris Institute for Transplantation and Organ Regeneration
- Study coordinator: Marc Raynaud, PhD
- Email: mrayna06@gmail.com
- Phone: +33613493009
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.